185 related articles for article (PubMed ID: 37090738)
1. Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status.
Aissatou A; Fokam J; Semengue ENJ; Takou D; Ka'e AC; Ambe CC; Nka AD; Djupsa SC; Beloumou G; Ciaffi L; Tchouaket MCT; Nayang ARM; Pabo WLT; Essomba RG; Halle EGE; Okomo MC; Bissek AZ; Leke R; Boum Y; Mballa GAE; Montesano C; Perno CF; Colizzi V; Ndjolo A
Front Immunol; 2023; 14():1155855. PubMed ID: 37090738
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
[TBL] [Abstract][Full Text] [Related]
3. Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic.
Kamga Wouambo R; Djuikoué CI; Esemu LF; Kagoue Simeni LA; Tchitchoua MC; Djouela Djoulako PD; Fokam J; Singwe-Ngandeu M; Mpoudi Ngolé E; Apalata T
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851621
[TBL] [Abstract][Full Text] [Related]
4. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon.
Essomba RG; Bayibeki AN; Lissom A; Ateba PT; Seni N; Fouda CAN; Mbitock SBD; Ebonda ND; Afana SD; Akame S; Tembu AA; Ngamaleu MR; Bimai BCB; Kabo O; Nguwoh PS; Ngounouh CT; Meka MCJ; Kengne M; Likeng JN; Kimessoukie EO; Nkoum BA; Assoumou MCO; Fokam J; Yap Boum II; Ambomo MS; Chadou MJP
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13222. PubMed ID: 37964992
[TBL] [Abstract][Full Text] [Related]
6. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies.
Ngomtcho SCH; Akenji BM; Tchio-Nighie KH; Fokam J; Guenou E; Nsa'Amang Eyebe C; Nzegni Kamkoum YJ; Ntale Tchoffo VD; Buh Nkum C; Tchoudjin Paho HC; Ebogo YMS; Nanfak A; Maidadi-Foudi M; Fouda C; Andigema AS; Nsah Bongdze-Em L; Nfor BN; Torimiro J; Zoung-Kanyi Bissek AC; Noubom M; Assoumou Okomo MC; Ateudjieu J
PLoS One; 2024; 19(5):e0304477. PubMed ID: 38820301
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
[TBL] [Abstract][Full Text] [Related]
9. False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy.
Latiano A; Tavano F; Panza A; Palmieri O; Niro GA; Andriulli N; Latiano T; Corritore G; Gioffreda D; Gentile A; Fontana R; Guerra M; Biscaglia G; Bossa F; Carella M; Miscio G; di Mauro L
Int J Infect Dis; 2021 Mar; 104():159-163. PubMed ID: 33383223
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of SARS -CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq.
Saeed AY; Assafi MS; Othman HE; Shukri HM
J Infect Dev Ctries; 2022 Jul; 16(7):1126-1130. PubMed ID: 35905016
[TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study.
Ghate M; Shidhaye P; Gurav S; Gadhe K; Kale V; Jain P; Thakar M
J Int Assoc Provid AIDS Care; 2022; 21():23259582221077943. PubMed ID: 35128977
[No Abstract] [Full Text] [Related]
14. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
[TBL] [Abstract][Full Text] [Related]
15. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women.
González R; Nhampossa T; Figueroa-Romero A; Mendes A; Mazuze M; García-Otero L; Sevene E; Piqueras M; Egri N; Bedini JL; Saúte F; Menendez C
J Acquir Immune Defic Syndr; 2023 Feb; 92(2):115-121. PubMed ID: 36287578
[TBL] [Abstract][Full Text] [Related]
17. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
[TBL] [Abstract][Full Text] [Related]
18. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.
Violán C; Torán-Monserrat P; Quirant B; Lamonja-Vicente N; Carrasco-Ribelles LA; Chacón C; Manresa-Dominguez JM; Ramos-Roure F; Dacosta-Aguayo R; Palacios-Fernández C; Roso-Llorach A; Pujol A; Ouchi D; Monteagudo M; Montero-Alia P; Garcia-Sierra R; Arméstar F; Doladé M; Prat N; Bonet JM; Clotet B; Blanco I; Boigues-Pons M; Moreno-Millán N; Prado JG; Cáceres EMM;
BMC Infect Dis; 2022 Sep; 22(1):721. PubMed ID: 36057544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
